Clinical trial
A Randomised, Open-label Study to Compare Plasma Concentrations of Aramchol in Healthy Volunteers After Once or Twice Daily Oral Dosing to Steady State
NCT03774173 is registered in ClinicalTrials.gov with Galmed Pharmaceuticals Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Open-label Study to Compare Plasma Concentrations of Aramchol in Healthy Volunteers After Once or Twice Daily Oral Dosing to Steady State
- Lead sponsor
- Galmed Pharmaceuticals Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 8, 2018
- Completion date
- March 5, 2019
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy